Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story Lacea Loader | Photo Supplied
Dr Cias Tsotsetsi
Dr Cias Tsotetsi, newly appointed Campus Vice-Principal: Academic and Research on the UFS Qwaqwa Campus.

The University of the Free State (UFS) is pleased to announce the appointment of Dr Cias Tsotetsi as the Campus Vice-Principal: Academic and Research on the UFS Qwaqwa Campus as from 1 January 2025.

He is currently Senior Lecturer and Assistant Dean in the Faculty of Education on the UFS Qwaqwa Campus. He holds the following qualifications: BEd(Hons), Postgraduate Diploma in Education, Magister Educationis with specialisation in Policy Studies and Governance in Education, and PhD with specialisation in Philosophy and Policy Studies in Education – all from the UFS.

Dr Tsotetsi operated in the school environment for about 24 years before joining this university in 2010. Since then, he has taught several modules in the Faculty of Education and published several co-authored research articles as well as conference papers on community engagement, teacher development, and participatory action research methodologies, among others. He is also well versed in supervising postgraduate students.

He has received awards from both the university’s Scholarship of Teaching and Learning and the Research committees for his research and academic scholastic performance. He is a member of various committees, such as the Faculty of Education Academic Advisory Board and the Committee for Title Registration and has been participating in partnerships and in NRF-funded projects with peers from universities such as the University of KwaZulu-Natal, the University of Zululand, the Durban University of Technology, and the University of Venda.

“Dr Tsotetsi has a clear understanding of the current systems and operations on the Qwaqwa Campus and is positioned to drive its development. His experience and initiatives involving staff and postgraduate students are exceptional and inspiring. We look forward to Dr Tsotetsi’s valuable contribution to the UFS Qwaqwa Campus and the institution in his new position,” says Prof Prince Ngobeni, Campus Principal of the Qwaqwa Campus.

“I feel honoured to serve the university – and the Qwaqwa Campus in particular – and look forward to working with the campus and its management to develop the research portfolio,” says Dr Tsotetsi. 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept